222 related articles for article (PubMed ID: 12378598)
1. DNA fragmentation and cell proliferation correlated with tumor grade in patients with hepatocellular carcinoma.
Kalogeraki A; Garbagnati F; Santinami M; Zoras O
Cancer; 2002 Oct; 96(5):301-5. PubMed ID: 12378598
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis and cell proliferation correlated with tumour grade in peritoneal fluids of patients with serous ovarian cancer.
Kalogeraki A; Karvela-Kalogeraki I; Petraki PE; Zois I; Tamiolakis D; Stathopoulos EN
Cytopathology; 2011 Dec; 22(6):383-6. PubMed ID: 20738358
[TBL] [Abstract][Full Text] [Related]
3. Cellular apoptosis susceptibility protein and proliferation in human hepatocellular carcinoma.
Shiraki K; Fujikawa K; Sugimoto K; Ito T; Yamanaka T; Suzuki M; Yoneda K; Sugimoto K; Takase K; Nakano T
Int J Mol Med; 2006 Jul; 18(1):77-81. PubMed ID: 16786158
[TBL] [Abstract][Full Text] [Related]
4. [Expression of caspase3 gene does not correlate with tumor cell apoptosis in primary hepatocellular carcinoma].
Sun B; Zhang J; Wang B
Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):39-41. PubMed ID: 11776594
[TBL] [Abstract][Full Text] [Related]
5. [Expression of cyclins in hepatocellular carcinoma and its correlation to tumor cell apoptosis].
Peng SH; Yang JF; Xie PP; Deng H; Li H; Feng DY
Ai Zheng; 2005 Jun; 24(6):695-8. PubMed ID: 15946481
[TBL] [Abstract][Full Text] [Related]
6. Expression of survivin mRNA associates with apoptosis, proliferation and histologically aggressive features in hepatocellular carcinoma.
Morinaga S; Nakamura Y; Ishiwa N; Yoshikawa T; Noguchi Y; Yamamoto Y; Rino Y; Imada T; Takanashi Y; Akaike M; Sugimasa Y; Takemiya S
Oncol Rep; 2004 Dec; 12(6):1189-94. PubMed ID: 15547736
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor, transforming growth factor alpha, and their receptors as combined markers of prognosis in hepatocellular carcinoma.
Daveau M; Scotte M; François A; Coulouarn C; Ros G; Tallet Y; Hiron M; Hellot MF; Salier JP
Mol Carcinog; 2003 Mar; 36(3):130-41. PubMed ID: 12619035
[TBL] [Abstract][Full Text] [Related]
8. Cell proliferation and cell loss in nodule-in-nodule hepatocellular carcinoma.
Yamamoto K; Takenaka K; Kajiyama K; Shimada M; Shirabe K; Taketomi A; Maeda T; Sugimachi K
Hepatogastroenterology; 1999; 46(26):813-9. PubMed ID: 10370619
[TBL] [Abstract][Full Text] [Related]
9. TNFRSF6B neutralization antibody inhibits proliferation and induces apoptosis in hepatocellular carcinoma cell.
Chen G; Rong M; Luo D
Pathol Res Pract; 2010 Sep; 206(9):631-41. PubMed ID: 20591579
[TBL] [Abstract][Full Text] [Related]
10. Growth index, assessed with Ki-67 and ssDNA labeling; a significant prognosticator for patients undergoing curative resection for hepatocellular carcinoma.
Morinaga S; Ishiwa N; Noguchi Y; Yamamoto Y; Rino Y; Imada T; Takanashi Y; Akaike M; Sugimasa Y; Takemiya S
J Surg Oncol; 2005 Dec; 92(4):331-6. PubMed ID: 16299800
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis, PCNA and p53 in hepatocellular carcinoma.
Paiva C; Oshima CT; Lanzoni VP; Forones NM
Hepatogastroenterology; 2002; 49(46):1058-61. PubMed ID: 12143201
[TBL] [Abstract][Full Text] [Related]
12. [The effects of p38MAPK and HBxAg on cell proliferation and apoptosis in human hepatocarcinogenesis].
Shen LJ; Guo W; Gao P; Yu J; Qian ZY; Zhang HX; Zhang ZJ
Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):227-30. PubMed ID: 22475145
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.
Ikeguchi M; Hirooka Y; Kaibara N
Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288
[TBL] [Abstract][Full Text] [Related]
14. Fine-needle aspiration cytology to distinguish dysplasia from hepatocellular carcinoma with different grades.
Lin CC; Lin CJ; Hsu CW; Chen YC; Chen WT; Lin SM
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e146-52. PubMed ID: 17532784
[TBL] [Abstract][Full Text] [Related]
15. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
[TBL] [Abstract][Full Text] [Related]
16. Relationship between p53 overexpression and the proliferative activity in hepatocellular carcinoma.
Itoh T; Shiro T; Seki T; Nakagawa T; Wakabayashi M; Inoue K; Okamura A
Int J Mol Med; 2000 Aug; 6(2):137-42. PubMed ID: 10891556
[TBL] [Abstract][Full Text] [Related]
17. [Expression of FADD in primary hepatocellular carcinoma and its relationship with hepatic apoptosis].
Sun B; Wang B; Zhao X
Zhonghua Gan Zang Bing Za Zhi; 2000 Feb; 8(1):37-9. PubMed ID: 10712784
[TBL] [Abstract][Full Text] [Related]
18. [The detection of protein expression of clusterin and Ki-67 and the status of cell apoptosis in bladder transitional cell carcinoma].
Chen W; Xie D; Luo JH; Wang CX; Tao Y; Zheng KL; Mei H
Zhonghua Wai Ke Za Zhi; 2006 Jan; 44(2):111-4. PubMed ID: 16620672
[TBL] [Abstract][Full Text] [Related]
19. [Regulation of p53 and bcl-2 proteins to apoptosis and cell proliferation in liver cirrhosis and hepatocellular carcinoma].
Feng D; Zheng H; Shen M; Cheng R; Yan Y
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):325-8. PubMed ID: 12080637
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic features of poorly differentiated hepatocellular carcinoma.
Oishi K; Itamoto T; Amano H; Fukuda S; Ohdan H; Tashiro H; Shimamoto F; Asahara T
J Surg Oncol; 2007 Mar; 95(4):311-6. PubMed ID: 17326126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
